Completed NA INTERVENTIONAL 3-arm NCT05072132

Returning Genetic Results on Arsenic Susceptibility

Returning Genetic Results on Arsenic Susceptibility to Bangladeshi Research Participants

Sponsor: University of Chicago

Interventions Personal information on genetic susceptibility to arsenic toxicity standard information on arsenic exposure reduction

Updated 6 times since 2021 Last updated: May 7, 2024 Started: Aug 16, 2021 Primary completion: Dec 31, 2022 Completion: May 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05072132, this NA trial focuses on Arsenic Exposure and remains completed. Sponsored by University of Chicago, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2024 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2023 — Jun 2024 [monthly]

Active Not Recruiting NA
Dec 2022 — Jun 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Nov 2021 — Dec 2022 [monthly]

Recruiting NA

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Chicago

Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh